23.01.2015 Views

WMJ 03 2010 - World Medical Association

WMJ 03 2010 - World Medical Association

WMJ 03 2010 - World Medical Association

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

WMA news<br />

tion were discussed and a special focus was<br />

placed on how to assure quality of care and<br />

education. Another discussion point was the<br />

financing of national health care systems.<br />

None of the international and multilateral<br />

donors report how much money from vertical<br />

programmes is allocated to human resources<br />

in health and to education. Money<br />

that is not reported money cannot be monitored<br />

and managed.<br />

The participants of the Seminar in Reykjavik<br />

on Human Resources for Health and<br />

the Future of Health Care last year defined<br />

ideas to facilitate WMA policy development<br />

in this area. The WMA Advocacy<br />

Working Group has considered the opportunity<br />

to collect best practices. Task shifting<br />

remains as a monitoring item of the Working<br />

Group.<br />

In March 2009, WMA was invited to take<br />

part in the planning process of the next<br />

Conference on Workplace Violence in<br />

the Health Sector, which is scheduled<br />

to take place from 27-29 October, <strong>2010</strong><br />

in Amsterdam. The event is supported by<br />

the Global Health Workforce Alliance<br />

(GHWA), WHO, International Labour<br />

Organisation (ILO), the International<br />

Council of Nurses (ICN), Public Services<br />

International (PSI) and other relevant<br />

health organizations.<br />

WHO is in the final stage of the development<br />

of guidelines on retention strategies<br />

for health professionals in rural areas. The<br />

objective is to attract and retain<br />

health care professionals in rural<br />

areas. The guidelines will be based<br />

on three pillars: educational and<br />

regulatory incentives, monetary<br />

incentives and management,<br />

environment and social support.<br />

Decision makers on the national<br />

and local levels and health facilities<br />

should receive evidence<br />

on the impact and effectiveness<br />

of various retention strategies<br />

that have been tried and tested.<br />

In November 2009 WHO, together<br />

with the Asian-Pacific<br />

Action Alliance on Human<br />

resources for Health (AAAH),<br />

held a conference to discuss with<br />

governments in Asia this topic<br />

in general and, in particular,<br />

how the guidelines need to be<br />

adapted to be better accepted by<br />

governments.<br />

WMA participates as a member<br />

of steering groups in two projects<br />

commissioned by the European<br />

Union on the Mobility and Migration<br />

of Health Professionals. One project<br />

is led by the European Health Care Management<br />

<strong>Association</strong> and the other by the<br />

Research Institute of the German Hartmann<br />

Bund, a private physicians organization.<br />

The general objective of the research<br />

projects is to assess the current trends in<br />

mobility and migration of health professionals<br />

to, from, and within the European<br />

Union, including their reasons<br />

for moving. Research will also<br />

be conducted in non-European<br />

sending and receiving countries,<br />

but the focus lies within<br />

the EU. This research project<br />

is a medium-scale collaborative<br />

project with a goal of facilitating<br />

informed policy decisions<br />

on health systems by developing<br />

a scientific evidence base related<br />

to the impact of mobility<br />

of health professionals.<br />

In January 2011 the Global Health Workforce<br />

Alliance will organise the 2nd Global<br />

Forum on Human Resources in Health<br />

(HRH) in Thailand. WMA is part of the<br />

thematic focus committee for this event. In<br />

an initial meeting, two main themes were<br />

proposed: improving quantity and quality<br />

of health workforce for equitable access to<br />

primary health care within a robust health<br />

system and financing HRH in the light of<br />

the global financial crisis.<br />

1.4 Counterfeit <strong>Medical</strong> Products<br />

Counterfeit medicines are manufactured<br />

which are below established standards of<br />

safety, quality and efficacy. They are deliberately<br />

and fraudulently mislabeled with<br />

respect to identity and/or source. Counterfeiting<br />

can apply to both brand name and<br />

generic products and counterfeit medicines<br />

may include products with the correct ingredients<br />

but fake packaging, with the<br />

89

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!